Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study.
Stephenson JJ, Gable JC, Zincavage R, Price GL, Churchill C, Zhu E, Stenger K, Singhal M, Nepal B, Grabner M, Fisch MJ, Debono D, Geschwender AR, Cuyun Carter G.
Stephenson JJ, et al.
Patient Prefer Adherence. 2021 Nov 3;15:2417-2429. doi: 10.2147/PPA.S319239. eCollection 2021.
Patient Prefer Adherence. 2021.
PMID: 34764640
Free PMC article.
They further reported appreciating the ease and convenience of oral oncolytics, coped with side effects, had strong medical and social support, and experienced few cost issues. ...Interview themes indicated several factors that likely contributed to the lack of adherence/p …
They further reported appreciating the ease and convenience of oral oncolytics, coped with side effects, had strong medical and socia …